What is the share price of Mukka Proteins Ltd (MUKKA) today?
The share price of MUKKA as on 24th March 2025 is ₹34.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mukka Proteins Ltd (MUKKA) share?
The past returns of Mukka Proteins Ltd (MUKKA) share are- Past 1 week: -2.30%
- Past 1 month: -3.35%
- Past 3 months: -12.32%
- Past 6 months: -20.38%
- Past 1 year: -6.67%
- Past 3 years: N/A%
- Past 5 years: -18.82%
What are the peers or stocks similar to Mukka Proteins Ltd (MUKKA)?
The peers or stocks similar to Mukka Proteins Ltd (MUKKA) include:What is the market cap of Mukka Proteins Ltd (MUKKA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mukka Proteins Ltd (MUKKA) is ₹1029 Cr as of 24th March 2025.What is the 52 week high and low of Mukka Proteins Ltd (MUKKA) share?
The 52-week high of Mukka Proteins Ltd (MUKKA) is ₹56.56 and the 52-week low is ₹30.What is the PE and PB ratio of Mukka Proteins Ltd (MUKKA) stock?
The P/E (price-to-earnings) ratio of Mukka Proteins Ltd (MUKKA) is 14.69. The P/B (price-to-book) ratio is 2.52.Which sector does Mukka Proteins Ltd (MUKKA) belong to?
Mukka Proteins Ltd (MUKKA) belongs to the Consumer Staples sector & Packaged Foods & Meats sub-sector.How to buy Mukka Proteins Ltd (MUKKA) shares?
You can directly buy Mukka Proteins Ltd (MUKKA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mukka Proteins Ltd
MUKKA Share Price
MUKKA Share Price Chart
MUKKA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MUKKA Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
17.23 | 2.52 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
47.05 | 9.03 | 1.58% |
MUKKA Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
MUKKA Company Profile
Mukka Proteins is an India-based company that operates in the fish protein industry.
MUKKA Similar Stocks (Peers)
Compare with peersMUKKA Forecasts
Price
Revenue
Earnings
MUKKA Share Price Forecast
MUKKA Company Revenue Forecast
MUKKA Stock EPS (Earnings Per Share) Forecast
MUKKA
Income
Balance Sheet
Cash Flow
MUKKA Income Statement
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 415.40 | 557.09 | 613.77 | 777.96 | 1,185.26 | 1,399.25 | 899.41 | |||||||
Raw Materials | 386.89 | 472.43 | 548.31 | 649.73 | 1,006.19 | 1,326.88 | 784.50 | |||||||
Power & Fuel Cost | 1.43 | 2.72 | 3.64 | 4.58 | 8.07 | 7.39 | ||||||||
Employee Cost | 5.87 | 8.31 | 14.97 | 19.36 | 24.66 | 29.33 | ||||||||
Selling & Administrative Expenses | 15.87 | 25.94 | 35.20 | 40.63 | 65.13 | 70.29 | ||||||||
Operating & Other expenses | -20.23 | 16.05 | -20.16 | 9.42 | -13.09 | -159.53 | ||||||||
EBITDA | 25.57 | 31.64 | 31.81 | 54.24 | 94.30 | 124.89 | 114.91 | |||||||
Depreciation/Amortization | 2.43 | 4.69 | 8.34 | 8.58 | 11.89 | 12.34 | 14.02 | |||||||
PBIT | 23.14 | 26.95 | 23.47 | 45.66 | 82.41 | 112.55 | 100.89 | |||||||
Interest & Other Items | 4.34 | 7.21 | 8.02 | 9.68 | 16.48 | 25.10 | 34.39 | |||||||
PBT | 18.80 | 19.74 | 15.45 | 35.98 | 65.93 | 87.45 | 66.50 | |||||||
Taxes & Other Items | 4.51 | 6.55 | 6.48 | 11.77 | 21.87 | 17.40 | 6.78 | |||||||
Net Income | 14.29 | 13.19 | 8.97 | 24.21 | 44.06 | 70.05 | 59.72 | |||||||
EPS | 0.65 | 0.60 | 0.41 | 1.10 | 2.00 | 2.69 | 1.99 | |||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MUKKA Company Updates
Annual report
PDFMUKKA Past Performance & Peer Comparison
Consumer StaplesPackaged Foods & Meats
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Mukka Proteins Ltd | 14.69 | 2.52 | — |
Patanjali Foods Ltd | 83.36 | 6.25 | 0.34% |
LT Foods Ltd | 22.32 | 3.86 | 0.13% |
Avanti Feeds Ltd | 35.63 | 4.73 | 0.67% |
MUKKA Stock Price Comparison
Compare MUKKA with any stock or ETFMUKKA Shareholdings
MUKKA Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MUKKA Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
MUKKA Shareholding Pattern
MUKKA Shareholding History
smallcases containing MUKKA stock
Looks like this stock is not in any smallcase yet.
MUKKA Events
MUKKA Dividend Trend
MUKKA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MUKKA Dividends
MUKKA Stock News & Opinions
The first order, valued at Rs 31.77 crore, is from Avanti Feeds for the supply of fish meal and oil, and it is to be executed immediately. In another order, the company has received an order from Mukka Proteins Vietnam, aggregating to $1,000,000 (equivalent to Rs 8.7 crore), which is to be executed immediately. The company also received a purchase order valued at $220,000 (equivalent to Rs 1.91 crore) from Padma Feed & Chicks for the supply of fish meal, which is to be executed immediately. Mukka Proteins manufactures fish protein products. The company produces and supplies fish meal, fish oil, and fish soluble paste, which are essential ingredients for the production of aqua feed (for fish and shrimp), poultry feed (for broilers and layers), and pet food (for dog and cat food). The company's consolidated net profit surged 150.8% to Rs 26.26 crore, despite a 41% drop in net sales to Rs 296.20 crore in Q3 FY25 compared to Q3 FY24.Powered by Capital Market - Live
Net profit of Mukka Proteins rose 150.81% to Rs 26.26 crore in the quarter ended December 2024 as against Rs 10.47 crore during the previous quarter ended December 2023. Sales declined 40.96% to Rs 296.20 crore in the quarter ended December 2024 as against Rs 501.66 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales296.20501.66 -41 OPM %13.963.76 - PBDT36.7720.65 78 PBT32.9717.47 89 NP26.2610.47 151 Powered by Capital Market - Live
Mukka Proteins will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
Mukka Proteins has been assigned the credit rating CARE BBB+; Stable/ CARE A2 for bank facilities of Rs 360 crore (enhanced from Rs 100 crore). Powered by Capital Market - Live
Net profit of Mukka Proteins declined 92.64% to Rs 2.08 crore in the quarter ended September 2024 as against Rs 28.27 crore during the previous quarter ended September 2023. Sales declined 55.34% to Rs 144.85 crore in the quarter ended September 2024 as against Rs 324.31 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales144.85324.31 -55 OPM %6.6011.72 - PBDT4.8137.93 -87 PBT1.0534.97 -97 NP2.0828.27 -93 Powered by Capital Market - Live
Mukka Proteins will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Mukka Proteins announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 November 2024 .Powered by Capital Market - Live
Mukka Proteins will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live
Mukka Proteins announced that the 14th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
Net profit of Mukka Proteins rose 17.83% to Rs 4.23 crore in the quarter ended June 2024 as against Rs 3.59 crore during the previous quarter ended June 2023. Sales declined 37.39% to Rs 166.71 crore in the quarter ended June 2024 as against Rs 266.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales166.71266.28 -37 OPM %8.365.40 - PBDT8.6610.92 -21 PBT5.548.06 -31 NP4.233.59 18 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 27.49%, vs industry avg of 13.26%
Over the last 5 years, market share increased from 0.66% to 1.33%
Over the last 5 years, net income has grown at a yearly rate of 37.43%, vs industry avg of 21.8%